Business Seminar

Speaker: 
Fumihiko Takeshita (Senior Director (R&D), Vaccine Business Intelligence Division, Daiichi Sankyo Co., Ltd.)
He is a medical doctor and he has experiences in the US Food and Drug Administration (FDA), Japanese national research institute and university. He is currently directing R&D of vaccine in Daiichi Sankyo.

Masahiko Kikuchi (Vice President, Vaccine Business Intelligence Division Vaccine Business Strategy Department, Daiichi Sankyo Co., Ltd.)
After graduating from the School of Pharmacy at the Kumamoto University, Dr. Kikuchi joined to Daiichi Pharmaceutical (Current Daiichi Sankyo).
He has carriers for 25 years about pharmaceutical research, management strategy and working abroad. Currently he is a director of vaccine business division.
Also, he serves as a professor of Advanced Pharmaceutical Sciences/Graduate School of Pharmaceutical Sciences at Kumamoto University.

Daiichi Sankyo was founded through the merger of Daiichi Pharmaceutical and Sankyo which have histories of 100 years. They aim to contribute to the enrichment of the quality of health and life around the world through the creation, the provision of innovative pharmaceuticals.
http://www.daiichisankyo.com/index.html

Date&Time:  6 Dec. (FRI.) 2013   
                    
13:15- 14:45  Fumihiko Takeshita
 Title: R&D of Medicine Harnessing Innate Immune System
 Abstract:
 Nobel Prizes of 2011 were dedicated to researches for discovery and subsequent elucidation of mechanisms, i.e., molecules and cells, involved in innate immune system. This lecture will introduce recent accumulating evidence showing how innate immune sensors and those cells installed with such sensors recognize pathogens. The lecturer has carrier as a medical doctor of internal medicine and a scientist of basic research field of vaccine and adjuvant in US Food and Drug Administration and Japanese National Institute of Infectious Diseases (regulatory authorities). He is trying to accelerate innovative R&D interactions among industries and academia to launch novel vaccines in the market.

15:00- 16:30  Masahiko Kikuchi
Title: Part 1: Current status and past successes of vaccines in Japan and overseas
         Part 2: Researcher views on what is required by companies
Abstract:
Part 1: Vaccination was discovered in the late 1800s when English physician Edward Jenner found that smallpox could be prevented by inoculating humans with cowpox virus (a bovine smallpox-like virus). Since then, many more vaccines have been developed in Japan and across the world. Approximately 30 infectious diseases are currently preventable by vaccines, and vaccines have made the largest contribution of any pharmaceutical class in the fields of preventive medicine, health and hygiene. The fundamentals of vaccines will be introduced in the initial presentation.
Part 2: Based on past experience, we would like to present viewpoints about what young researchers require to succeed in the future.

Venue:  Lecture room1 (3F), Medical Education & Library Building